InvestorsHub Logo
Followers 2
Posts 104
Boards Moderated 0
Alias Born 06/30/2009

Re: GWMAN post# 1047

Monday, 10/26/2009 11:17:24 AM

Monday, October 26, 2009 11:17:24 AM

Post# of 18434
could very well be 'all of the above', of the sum total of the reasons you mention. One thing that becomes obvious with the increased visibility of the range of applications possible with the hemopurifier, is that AEMD is NOT a one-trick pony. That fact, combined with the bargain level share price versus the potential of even just a part of any one of these market opps is what is driving the buying.

regarding Friday's Nephrology Conf presentation by the MD from India; if we see results that are considered (just)'good', then that would be great news as we are in need of real-world clinical results. If the results are powerfully positive, then even more of a further boost for shareprice and visibility of AEMD.

Barry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News